Safety threshold of intravitreal activated protein-C

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Graefe's Archive for Clinical and Experimental Ophthalmology

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00417-010-1566-8PMID 21107855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activated protein C rescues the retina from ischemia-induced cell death.

  2011influential reference
• Activated protein C prevents glutamate- and thrombin-induced activation of nuclear factor-kappaB in cultured hippocampal neurons.

  2010cited by this paper
• Hypoxia-ischemia and retinal ganglion cell damage

  2008cited by this paper
• Activated protein C in sepsis: the promise of nonanticoagulant activated protein C

  2008cited by this paper
• ACTIVATED PROTEIN C SUPPRESSES ADRENOMEDULLIN AND AMELIORATES LIPOPOLYSACCHARIDE-INDUCED HYPOTENSION

  2007cited by this paper
• Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.

  2006cited by this paper
• Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

  2006cited by this paper
• Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

  2005cited by this paper
• Functional recovery after embolic stroke in rodents by activated protein C

  2005cited by this paper
• Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.

  2005cited by this paper
• INTRAVITREAL TOXICITY OF THE KENALOG VEHICLE (BENZYL ALCOHOL) IN RABBITS

  2004influential reference
• RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW

  2004cited by this paper
• Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3.

  2004cited by this paper
• Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C

  2004cited by this paper
• Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model.

  2003cited by this paper
• Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1.

  2003cited by this paper
• Retinal and choroidal neovascularization

  2000cited by this paper
• Retinal toxicity secondary to intraocular gentamicin injection.

  1986cited by this paper
• Experimental intravitreal gentamicin.

  1976cited by this paper

• 3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina

  2023cites this paper
• Activated protein C induces suppression and regression of choroidal neovascularization- A murine model.

  2019cites this paper
• Intraocular Pressure Changes: An Important Determinant of the Biocompatibility of Intravitreous Implants

  2011cites this paper